• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Fierce Biotech Layoff Tracker 2023: Bayer-bought BlueRock makes cuts; Alaunos lets go 60%...

cafead

Administrator
Staff member
  • cafead   Aug 18, 2023 at 10:33: AM
via We had hoped that our Layoff Tracker would stay retired for a while. We certainly had no plans to bring it back within the same week, but 2023 is starting to look a lot like our old friend 2022 when it comes to layoffs in biotech.

article source